Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 17 studies | 24% ± 10% | |
adipocyte | 9 studies | 43% ± 15% | |
adventitial cell | 3 studies | 22% ± 3% | |
myofibroblast cell | 3 studies | 28% ± 15% | |
connective tissue cell | 3 studies | 39% ± 27% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
adipose | 3 studies | 44% ± 32% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 99% | 1679.82 | 242 / 245 | 92% | 9.15 | 460 / 502 |
breast | 100% | 2700.90 | 458 / 459 | 84% | 7.70 | 944 / 1118 |
uterus | 100% | 2382.46 | 170 / 170 | 84% | 14.41 | 385 / 459 |
ovary | 100% | 2344.13 | 180 / 180 | 67% | 8.20 | 289 / 430 |
esophagus | 86% | 667.24 | 1249 / 1445 | 80% | 9.37 | 147 / 183 |
lung | 82% | 563.39 | 474 / 578 | 73% | 5.71 | 840 / 1155 |
skin | 100% | 4918.90 | 1803 / 1809 | 50% | 5.15 | 238 / 472 |
bladder | 100% | 1338.71 | 21 / 21 | 46% | 3.76 | 234 / 504 |
intestine | 83% | 954.77 | 798 / 966 | 46% | 2.77 | 241 / 527 |
stomach | 46% | 498.45 | 164 / 359 | 62% | 4.62 | 176 / 286 |
adipose | 100% | 3436.64 | 1204 / 1204 | 0% | 0 | 0 / 0 |
thymus | 78% | 508.34 | 508 / 653 | 18% | 0.82 | 109 / 605 |
blood vessel | 91% | 679.66 | 1211 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 89% | 15.00 | 71 / 80 |
pancreas | 0% | 0.90 | 1 / 328 | 81% | 5.66 | 144 / 178 |
tonsil | 0% | 0 | 0 / 0 | 80% | 6.22 | 36 / 45 |
lymph node | 0% | 0 | 0 / 0 | 59% | 3.02 | 17 / 29 |
adrenal gland | 28% | 121.14 | 73 / 258 | 23% | 2.13 | 54 / 230 |
heart | 39% | 236.59 | 333 / 861 | 0% | 0 | 0 / 0 |
kidney | 6% | 28.35 | 5 / 89 | 9% | 0.68 | 82 / 901 |
brain | 0% | 0.12 | 1 / 2642 | 12% | 1.18 | 88 / 705 |
liver | 0% | 0 | 0 / 226 | 12% | 1.89 | 50 / 406 |
spleen | 10% | 37.25 | 23 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 3% | 14.92 | 31 / 929 | 0% | 0 | 0 / 0 |
muscle | 2% | 9.88 | 18 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0032868 | Biological process | response to insulin |
GO_0014070 | Biological process | response to organic cyclic compound |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0030335 | Biological process | positive regulation of cell migration |
GO_0030154 | Biological process | cell differentiation |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0032502 | Biological process | developmental process |
GO_0045668 | Biological process | negative regulation of osteoblast differentiation |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0005730 | Cellular component | nucleolus |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
GO_0046983 | Molecular function | protein dimerization activity |
GO_0005515 | Molecular function | protein binding |
Gene name | TWIST2 |
Protein name | Twist-related protein 2 (Class A basic helix-loop-helix protein 39) (bHLHa39) (Dermis-expressed protein 1) (Dermo-1) |
Synonyms | BHLHA39 DERMO1 |
Description | FUNCTION: Binds to the E-box consensus sequence 5'-CANNTG-3' as a heterodimer and inhibits transcriptional activation by MYOD1, MYOG, MEF2A and MEF2C. Also represses expression of pro-inflammatory cytokines such as TNFA and IL1B. Involved in postnatal glycogen storage and energy metabolism (By similarity). Inhibits the premature or ectopic differentiation of preosteoblast cells during osteogenesis, possibly by changing the internal signal transduction response of osteoblasts to external growth factors. . |
Accessions | ENST00000710607.1 ENST00000448943.2 ENST00000710608.1 Q8WVJ9 ENST00000671947.1 ENST00000612363.2 ENST00000673387.1 |